Medical disclaimer: This page is for informational purposes only and does not replace advice from a licensed clinician. Weight-loss medication should be used only under medical supervision.

Advertiser disclosure: BestMedsHub may receive compensation from partners featured on this page. Read our Advertiser Disclosure.

Quick answer

As of 2026, Medicare Part D covers Wegovy (semaglutide 2.4mg) for patients with BMI 27+ and established cardiovascular disease, following the SELECT trial results. This is a significant expansion — Medicare previously excluded all obesity medications. Coverage is limited to the cardiovascular indication, not obesity alone. Compounded semaglutide is NOT covered by Medicare. Patients without cardiovascular disease can access compounded GLP-1 through cash-pay telehealth programs ($145-199/month).

What Medicare Now Covers

The landmark change in 2026: Medicare Part D now covers brand-name Wegovy for patients who meet specific criteria. This followed the SELECT cardiovascular outcomes trial showing semaglutide reduces major cardiac events by 20%.

Eligibility Requirements

BMI 27+ (overweight or obese)
Established cardiovascular disease (prior heart attack, stroke, or peripheral artery disease)
Wegovy specifically (not Ozempic, not compounded semaglutide)
Prior authorization required — your provider submits documentation
Typical Part D copay: $35-95/month

If You Do Not Qualify for Medicare Coverage

Medicare beneficiaries without cardiovascular disease can still access GLP-1 treatment through cash-pay telehealth programs. Compounded semaglutide at $145-199/month is significantly cheaper than brand-name Wegovy out-of-pocket.

Bottom Line

Medicare GLP-1 coverage is expanding but still limited. If you have cardiovascular disease and Medicare, talk to your provider about Wegovy coverage. Otherwise, cash-pay telehealth programs offer affordable access. Compare providers →

Compare Top Weight Loss Providers

See how pricing, medication options, and provider support compare.

Go to the Weight Loss Comparison Hub →

Frequently Asked Questions

Does Medicare pay for weight loss medication?

As of 2026, Medicare Part D covers Wegovy for patients with BMI 27+ AND established cardiovascular disease. General obesity coverage is not yet available.